Simon Edelsten and Alex Illingworth, managers of the Mid Wynd International Investment Trust, tell us why governance issues played a key role in their decision to sell all of their holdings in China. The pair also discuss the role of healthcare and automation as key themes in their portfolio and why they hold Pfizer despite being adverse to large pharmaceutical companies. The managers also tell us why the best returns from wind farms, as a low carbon theme, are behind us.

Learn more on fundcalibre.com

Please remember, we’ve been discussing individual companies to bring investing to life for you. It’s not a recommendation to buy or sell. The fund may or may not still hold these companies at the time of listening. Elite Ratings are based on FundCalibre’s research methodology and are the opinion of FundCalibre’s research team only.